|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01011 NT PHARMA
Nominal 
0.275 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 31,297 | -62.114% | 82,609 | 120,501 | 111,233 | 89,436 |
| Cost of Sales | (25,591) | -15.558% | (30,306) | (45,630) | (39,572) | (32,738) |
| Gross Profit | 5,706 | -89.090% | 52,303 | 74,871 | 71,661 | 56,698 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | 1,794 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 7,893 | -28.486% | 11,037 | 7,807 | 0 | (133) | |
| Profit / (Loss) before Taxation | 785 | -- | (5,612) | (27,289) | (3,594) | (48,499) | |
| Taxation | (124) | -- | 0 | (949) | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | (36,462) | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 940 | 1,754 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 661 | -- | (5,612) | (28,238) | (2,654) | (83,207) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 6,003 | -82.277% | 33,871 | 34,865 | 31,696 | 26,047 |
| Depreciation & Amortisation | 511 | -95.150% | 10,537 | 11,275 | 15,497 | 11,672 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 0.030 | -- | -2.500 | -14.900 | -1.400 | -43.700 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | (0.131) | -- | (1.042185) | (1.226828) | 0.097903 | 0.285283 |
| Remarks: | Real time quote last updated: 27/12/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 661,000 |
| %Change | -- |
| EPS / (LPS) | RMB 0.000 |
| NBV Per Share (¥) | RMB -0.131 |